Harmony Biosciences Holdings share price logo

Harmony Biosciences Holdings

NASDAQ: HRMY

Mid Cap

$42.13

+0.11

(+0.26%)

as on

Harmony Biosciences Holdings Stock Performance

as on September 22, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $41.20
    $42.52
    downward going graph

    2.21%

    Downside

    0.93%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $25.52
    $43.49
    downward going graph

    39.43%

    Downside

    3.23%

    Upside

    downward going graph

Harmony Biosciences Holdings share price movements today

Previous Close
$42.02
Open
$41.50
Volume
881.9K
Market Cap
$2.4B
Day's Low - High
$41.20 - $42.52
52 Week Low - High
$25.52 - $43.49

Harmony Biosciences Holdings Historical Returns

1 Month Return
+ 10.14 %
3 Month Return
+ 26.26 %
1 Year Return
+ 29.13 %
3 Year Return
+ 17.64 %
5 Year Return
+ 8.83 %

Harmony Biosciences Holdings Stock Fundamentals & Key Indicators

Check Harmony Biosciences Holdings market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.4B

EPS (TTM)

3.13

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.88%

PE Ratio (TTM)

13.47

Industry PE ratio

-13.56

PEG Ratio

-10.677228434504858

EBITDA

276.4M

Revenue (TTM)

959.9M

Profit Margin

75.42%

Return On Equity TTM

20.06%

Harmony Biosciences Holdings Stock Valuation

Track how Harmony Biosciences Holdings P/E has moved over time to understand its valuation trends.

Harmony Biosciences Holdings in the last 5 years

  • Overview

  • Trends

Lowest (13.44x)

December 31, 2024

Industry (-13.56x)

December 31, 2025

Today (13.56x)

December 31, 2025

Highest (70.91x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: 13.56x

Harmony Biosciences Holdings vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Harmony Biosciences Holdings with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$2.4B8.83%13.4775.42%0.00%
Neutral$61.5B-64.51%-19.3-12.57%0.00%
StrongBuy$130.1B174.21%29.8186.04%0.00%
Buy$80.8B21.32%18.4884.86%0.47%

Stock Returns calculator for Harmony Biosciences Holdings Stock including INR - Dollar returns

The Harmony Biosciences Holdings stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Harmony Biosciences Holdings investment value today

Current value as on today

₹1,40,471

Returns

₹40,471

(+40.47%)

Returns from Harmony Biosciences Holdings Stock

₹29,471 (+29.47%)

Dollar Impact

₹11,000 (+11%)

Analyst Recommendation on Harmony Biosciences Holdings Stock

Based on 9 analysts

BUY

44.44%

Buy

44.44%

Hold

11.11%

Sell

Based on 9 analysts, 44.44444444444444% of analysts recommend a 'BUY' rating for Harmony Biosciences Holdings. Average target price of $47.36

Harmony Biosciences Holdings Share Price Target

Get share price movements and forecasts by analysts on Harmony Biosciences Holdings.

What analysts predicted

11.04%UPSIDE

Target Price

$47.36

Current Price

$42.13

Analyzed by

9 Analysts

Target

$47.36

Harmony Biosciences Holdings target price $47.36, a slight upside of 11.04% compared to current price of $42.13. According to 9 analysts rating.

Indian Investors' Interest in Harmony Biosciences Holdings Stock

Search interest for Harmony Biosciences Holdings Stock has decreased by -13% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-13% versus previous 30 day period

Harmony Biosciences Holdings Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
154
172
186
201
184
200
239
243
215
261
Gross Profit
127
140
143
146
152
162
179
175
170
198
Operating Income
52
21
61
55
56
48
65
38
37
89
EBITDA
62
32
72
66
66
59
73
51
48
102
Interest Expense
4
4
4
4
3
3
3
3
3
3
Depreciation
6
6
5
5
5
5
5
7
5
5
Income Before Tax
51
21
62
56
57
49
67
40
39
93
Income Tax Expense
13
10
16
6
11
9
16
18
7
17
Net Income
38
11
46
49
45
39
50
22
32
75
Net Profit Margin
82.22%
81.40%
77.01%
72.97%
82.68%
80.97%
75.09%
71.88%
79.33%
75.81%

Harmony Biosciences Holdings Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
5
159
305
437
582
714
868
Gross Profit
0
4
132
249
354
460
557
670
Operating Income
-41
-145
16
87
120
192
190
208
EBITDA
-41
-142
1
80
146
221
233
255
Interest Expense
-
6
28
24
18
23
17
14
Depreciation
0
3
10
18
23
24
24
25
Income Before Tax
-39
-151
-36
37
104
173
191
215
Income Tax Expense
-
-
-
2
-76
44
46
56
Net Income
-39
-151
-36
34
181
128
145
158
Net Profit Margin
0.00%
73.69%
82.64%
81.82%
80.93%
79.17%
78.06%
77.16%

Harmony Biosciences Holdings Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
38
11
46
49
45
39
50
22
32
75
Operating Cash Flow
31
42
70
75
33
79
108
126
27
92
Investing Cash Flow
-6
-54
0
-7
2
-19
-4
-17
-183
-131
Financing Cash Flow
-3
-3
-1
-2
0
-2
-2
-3
-7
0
Change in Cash
21
-15
70
65
35
57
100
105
-163
-39

Harmony Biosciences Holdings Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-39
-151
-36
34
181
128
145
-
Operating Cash Flow
-38
-75
-2
98
144
219
219
348
Investing Cash Flow
-1
-127
-2
-100
-141
-46
-67
-39
Financing Cash Flow
21
143
209
7
6
-105
-10
-9
Change in Cash
-18
-58
204
5
9
67
141
299

Mutual Funds that own Harmony Biosciences Holdings Stock

Check out the Mutual Funds with significant holdings in Harmony Biosciences Holdings.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
6.498245%
3784344
Fidelity Mt. Vernon Street Trust
2.21813%
1291759
DFA INVESTMENT DIMENSIONS GROUP INC
1.865769%
1086557
Fidelity Salem Street Trust
0.810257%
471865
Fidelity Concord Street Trust
0.702126%
408893

Global Institutional Holdings in Harmony Biosciences Holdings

Funds
Holdings
iShares
8.64%
Vanguard
7.78%
Avantis
4.9%
SPDR
1.85%
Dimensional
1.83%

Harmony Biosciences Holdings News & Key Events

  • img

    Today's Timeline - 30 July

    Thu, 08:28 PM

    -

    Harmony Biosciences' earnings estimates decreased; missed earnings in past four quarters with a negative surprise average of 25.16%.

Insights on Harmony Biosciences Holdings

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 215.38M → 261.27M (in $), with an average increase of 17.6% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 22.48M → 75.43M (in $), with an average increase of 43.9% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, HRMY stock has moved up by 10.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 54.1% return, outperforming this stock by 38.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 480.0% return, outperforming this stock by 450.4%

About Harmony Biosciences Holdings

Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical firm dedicated to developing and marketing therapies for individuals in the United States who suffer from rare neurological conditions. Their flagship product, WAKIX, is a prescription medication designed to treat excessive daytime sleepiness in adult patients diagnosed with narcolepsy. The company, which was founded in 2017, was formerly known as Harmony Biosciences II, Inc. before adopting its current name in February 2020. Harmony Biosciences Holdings, Inc. operates out of Plymouth Meeting, Pennsylvania.
OrganisationHarmony Biosciences Holdings
Headquarters630 West Germantown Pike, Plymouth Meeting, PA, 19462, US
IndustryBiotechnology
CEOJeffrey Dayno
E-voting on sharesClick here to vote

Key Management of Harmony Biosciences Holdings

Name

Title

Mr. Jeffrey S. Aronin

Founder & Non-Executive Chairman

Dr. Jeffrey M. Dayno M.D.

President, CEO & Director

Dr. Kumar Budur M.D., M.S.

Executive VP and Chief Medical & Scientific Officer

Mr. Andrew Serafin J.D., M.B.A.

Executive VP & Chief Strategy Officer

Brennan Doyle

VP & Head of Investor Relations

Ms. Tricia Glover

Chief Compliance Officer

Mr. Peter Anastasiou

Chief Operating Officer

Mr. Adam Zaeske

Executive VP & Chief Commercial Officer

Mr. Stephen Mollichella

Senior VP, Controller & Interim Principal Financial Officer

Mr. Christian Ulrich J.D.

Executive VP, General Counsel & Corporate Secretary

FAQs

What is Harmony Biosciences Holdings share price today?

Harmony Biosciences Holdings share price today is $42.13 as on at the close of the market. Harmony Biosciences Holdings share today touched a day high of $42.52 and a low of $41.20.

What is the 52 week high and 52 week low for Harmony Biosciences Holdings share?

Harmony Biosciences Holdings share touched a 52 week high of $43.49 on and a 52 week low of $25.52 on . Harmony Biosciences Holdings stock price today i.e. is closed at $42.13,which is 3.13% down from its 52 week high and 65.09% up from its 52 week low.

What is Harmony Biosciences Holdings's market capitalisation today?

Harmony Biosciences Holdings market capitalisation is $0.00T as on .

How to invest in Harmony Biosciences Holdings Stock (HRMY) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Harmony Biosciences Holdings on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Harmony Biosciences Holdings Shares that will get you 0.0356 shares as per Harmony Biosciences Holdings share price of $42.13 per share as on September 22, 2026 at 1:29 am IST.

What is the minimum amount required to buy Harmony Biosciences Holdings Stock (HRMY) from India?

Indian investors can start investing in Harmony Biosciences Holdings (HRMY) shares with as little as ₹95.805 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.05 in Harmony Biosciences Holdings stock (as per the Rupee-Dollar exchange rate as on ). Based on Harmony Biosciences Holdings share’s latest price of $42.13 as on September 22, 2026 at 1:29 am IST, you will get 0.2374 shares of Harmony Biosciences Holdings. Learn more about fractional shares .

What are the returns that Harmony Biosciences Holdings has given to Indian investors in the last 5 years?

Harmony Biosciences Holdings stock has given 8.83% share price returns and 30.09% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?